News

Home discharge with total artificial heart is feasible, safe


 

AT THE STS ANNUAL MEETING

"All these patients remained stable and had no changes in cardiac output," Dr. Kasirajan pointed out. "They were able to switch to the backup driver as educated, and returned to the hospital."

Valsalva maneuvers can cause a sudden transient rise in intrathoracic pressure that a device sensor interprets as outside the set parameters, he explained; the software has since been modified to allow for these changes.

"The importance of hypertension management is critical," he commented. "The pump tolerates blood pressures at high levels for brief periods of time; however, prolonged hypertension leads to a decrease in left heart cardiac output and pulmonary edema."

The cases of hemolysis were due to transient rises in plasma free hemoglobin as a result of hemothorax and hydralazine-induced hemolytic anemia.

Only a single patient, in the out-of-hospital group, died before transplantation. This patient was stable on the driver for 437 days, but experienced a fall with a spinal cord hematoma, and developed fatal complications.

Dr. Kasirajan disclosed that he is a consultant to SynCardia Systems.

Pages

Recommended Reading

Vitamin D lowered aldosterone in heart failure
MDedge Cardiology
Comprehensive mechanical circulatory support guidelines issued
MDedge Cardiology
Atrial fib ablation in heart failure shows promise
MDedge Cardiology
CMS Revisits VAD Coverage Criteria
MDedge Cardiology
Aldo-DHF published: Spironolactone aids LV function but not symptoms
MDedge Cardiology
Anemia treatment not beneficial in heart failure
MDedge Cardiology
Aliskiren doesn't help heart failure patients, may harm diabetics
MDedge Cardiology
Sildenafil falls short for heart failure with preserved ejection fraction
MDedge Cardiology
Old gout drug learns new cardiac tricks
MDedge Cardiology
Panel backs approval of percutaneous mitral valve repair device
MDedge Cardiology